Prophylactic use of vacuum-assisted closure system for cannula sites: A case of extracorporeal biventricular assist devices for 295 days.
Yoshiyuki TakamiShin-Ichi TanidaNaoki HoshinoYusuke SakuraiKentaro AmanoKiyotoshi AkitaRyosuke HayashiAtsuo MaekawaHideo IzawaYasushi TakagiPublished in: The International journal of artificial organs (2021)
We report wound management using a vacuum-assisted closure (VAC) system for the cannula sites of extracorporeal biventricular assist devices (BiVADs) for 295 days in a 23-year old Chinese female patient with fulminant giant cell myocarditis, who finally underwent heart transplantation. When the cannula sites appeared necrotic 3 months after BiVADs placement, she received negative pressure wound therapy prophylactically for four cannula sites, using a VAC system for 3 months, followed by no infections. Such prophylactic VAC therapy, using the skin barrier paste usually used for the ostomy pouching system to create a flatter surface and airtightness, may be useful to avoid cannula site infections, which is still a fatal complication causing sepsis, especially in patients with extracorporeal BiVADs.
Keyphrases
- respiratory failure
- extracorporeal membrane oxygenation
- positive airway pressure
- giant cell
- obstructive sleep apnea
- acute respiratory distress syndrome
- intensive care unit
- wound healing
- mechanical ventilation
- acute kidney injury
- sleep apnea
- heart failure
- stem cells
- case report
- left ventricular
- cardiac resynchronization therapy
- septic shock
- bone marrow
- soft tissue